Renal Neoplasm
9
3
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
NSAID Use After Robotic Partial Nephrectomy
Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy
LPN in Patients With High-complex Renal Tumors
Laparoscopic Partial Nephrectomy for cT1 Tumors
Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2